Please assess the completion status of the following clinical trial:

Trial Title: Prospective Observational Study of Concomitant Allergic Rhinitis Treatment Patterns Among Patients Starting on Fluticasone Furoate Nasal Spray in a Retail Pharmacy Setting

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Active seasonal allergic rhinitis~* Initiating first-time treatment with fluticasone furoate nasal spray (FFNS)~* Received treatment with at least one intra-nasal steroid (INS) other than FFNS during the last allergy season~* Received treatment with one or more antihistamines, leukotriene receptor atagonists (LTRA), topical ocular medications, or any over the counter (OTC) medication for allergic rhinitis symptoms during the last allergy season~* At least 18 years of age at the time of study enrollment~* Able to read, comprehend, and record information in English~* Have provided an appropriately signed and dated informed consent~Exclusion Criteria:~* Received prior treatment with FFNS~* Pregnant~* Employee or family members of an employee of the study sponsor, retail pharmacy chain, or convenient care clinic implementing the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- New prescription for fluticasone furoate nasal spray (Type: None): patients receiving their first prescription for fluticasone furoate nasal spray and who have active seasonal allergic rhinitis with a history of using another intranasal steriod (INS) and other concomitant allergic rhinitis medications to treat their seasonal allergy symptoms.

Based on this trial design, predict the completion outcome and termination type (if applicable).